Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trandolapril for maintenance of sinus rhythm after electrical cardioversion in long-standing persistent atrial fibrillation
2004-002013-36Phase 4Active
- Sponsor
- Concepción Moro Serrano
- Start
- May 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of captopril in Atrial fibrillation (AFib) (2 arms), sponsored by Concepción Moro Serrano. Primary endpoints: Time to first recurrence of atrial fibrillation and Safety of amiodarone plus trandolapril. Started May 2005; status: active.
02
Drugs
captopril
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on 2004-002013-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002013-36.